How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | APHDVERDE BIO HOLDINGS, INC. | TAOXTAO Synergies Inc. | LTCHLatch, Inc. | VIPVulcan Infrastructure & Power Inc. | Median of the restexcluding APHD |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $1.00▼ 0.27 (21.26%) | $3.35▼ 0.20 (5.50%) | $0.158▼ 0.02 (11.73%) | $1.26▲ 0.00 (0.00%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 2.0/10 | 4.0/10 | 6.0/10 | 3.3/10 | 4.0/10 |
| Market value | $21.8M | $25.0M | $25.8M | $19.9M | |
| Revenue | — | $299.1K | $70.1M | $58.8M | |
| Profit | -$1.9M | -$28.7M | -$53.7M | $5.3M | |
| Revenue growthChange in sales versus the prior year. | — | — | 23.8% | -1.3% | 11.3% |
| Gross marginShare of sales left after the direct cost of producing them. | — | 87.2% | 38.3% | — | 62.7% |
| Operating marginShare of sales left after running the business, before interest and tax. | — | -3025.2% | -75.2% | -6.5% | -75.2% |
| Profit marginProfit kept from each dollar of sales. | — | -9609.2% | -76.7% | 9.0% | -76.7% |
| Free cash flow marginCash left after capital spending, as a share of sales. | — | — | -51.3% | — | -51.3% |
| Return on equityProfit against the owners' stake in the company. | -84.2% | -136.5% | -92.6% | -11.4% | -92.6% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | -59.3% | -46.0% | -148.6% | — | -97.3% |
| P/E ratioPrice paid per dollar of annual profit. | — | — | — | 3.77x | 3.77x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | — | — | 5.42x | 5.42x |
| Price to book | 9.84x | 1.19x | 0.45x | -0.43x | 0.45x |
| Debt to equityTotal liabilities compared with owners' stake. | 0.83x | 0.19x | 0.84x | -2.16x | 0.19x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 2/6 | 2/7 | 5/9 | 4/8 | 4.0 |
| Bankruptcy riskAltman Z-Score zone. | distress | n/a for banks | distress | n/a for banks |
How APHD compares with the others
- Its liabilities are higher relative to equity than the median of the other companies selected: 0.8x against 0.2x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.